Mastocytosis in children: A protocol for management

Pediatric Dermatology

Volumn 25, Issue 4, 2008, Pages 493-500

  Heide, Rogier ^a,c   Beishuizen, Auke ^a   De Groot, Hans ^a   Den Hollander, Jan C ^a   Van Doormaal, Jasper J ^d,e   De Monchy, Jan G R ^d,e   Pasmans, Suzanne G M A ^f   Van Gysel, Dirk ^g   Oranje, Arnold P ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Medisch Centrum Alkmaar ^*  (Netherlands)

^c Location Alkmaar   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e ECNM European Competence Network Mastocytosis

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g OLV HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; CALCIUM; CLEMASTINE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; KETOPROFEN; RANITIDINE;

ANAMNESIS; ARTICLE; BONE MARROW BIOPSY; CALCIUM INTAKE; CELL STRUCTURE; CLINICAL EVALUATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIFFUSE CUTANEOUS MASTOCYTOSIS; FOLLOW UP; LABORATORY TEST; MACULOPAPULOUS MASTOCYTOSIS; MASTOCYTOSIS; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DISEASE; SKIN TEST; SYSTEMIC THERAPY; TOPICAL TREATMENT; URTICARIA PIGMENTOSA;

CHILD; HUMANS; MASTOCYTOSIS; MASTOCYTOSIS, CUTANEOUS;

EID: 49349090384     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2008.00738.x     Document Type: Article

References (25)

1. Van Gysel D, Oranje AP. Mastocytosis. In : Harper JI, Oranje AP, Prose NP, eds. Textbook of pediatric dermatology, 2nd edn. London : Blackwell Science, 2006, 703 713.
2. Pardani A, Akin C, Valent P. Pathogenesis, clinical features, and treatment advances in mastocytosis. Best Pract Res Clin Haematol 2006 19 : 595 615.
3. Brockow K, Akin C, Huber M et al. Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathology. J Am Acad Dermatol 2003 48 : 508 516.
4. Ben-Amitai D, Metzker A, Cohen HA. Pediatric cutaneous mastocytosis: a review of 180 patients. Isr Med Assoc J 2005 7 : 320 322.
5. Hannaford R, Rogers M. Presentation of cutaneous mastocytosis in 173 children. Australas J Dermatol 2001 42 : 15 21.
6. Middelkamp Hup MA, Heide R, Tank B et al. Comparison of mastocytosis with onset in children and adults. J Eur Acad Dermatol Venereol 2002 16 : 115 120.
7. Akin C. Molecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology. J Mol Diagn 2006 8 : 412 419.
8. Valent P. Diagnostic evaluation and classification of mastocytosis. Immunol Allergy Clin North Am 2006 26 : 515 534.
9. Verzijl A, Heide R, Oranje AP et al. C-kit Asp-816-Val mutation analysis in patients with mastocytosis. Dermatology 2007 214 : 15 20.
10. Hartmann K, Metcalfe DD. Pediatric mastocytosis. Hematol Oncol Clin North Am 2000 14 : 625 640.
11. Yanagihori H, Oyama N, Nakamura K et al. c-kit Mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation. J Mol Diagn 2005 7 : 252 257.
12. Valent P, Horny HP, Escribano L et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001 25 : 603 625.
13. Horny HP, Sotlar K, Valent P. Mastocytosis: state of art. Pathobiology 2007 74 : 121 132.
14. Hartmann K, Henz BM. Classification of cutaneous mastocytosis: a modified consensus proposal Leuk Res 2002 26 : 483 484.
15. Heide R, de Waard-van der Spek FB, den Hollander JC et al. Efficacy of 25% diluted fluticasone propionate 0.05% cream as wet-wrap treatment in cutaneous mastocytosis. Dermatology 2007 214 : 333 335.
16. Valent P, Sperr WR, Schwartz LB et al. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms. J Allergy Clin Immunol 2004 114 : 3 11.
17. Janssens AS, Heide R, den Hollander JC et al. Mast cell distribution in normal adult skin. J Clin Pathol 2005 58 : 285 289.
18. James PD, Krafchik BR, Johnston AE. Cutaneous mastocytosis in children: anaesthetic considerations. Can J Anaesth 1987 34 : 522 524.
19. Borgeat A, Ruetsch YA. Anesthesia in a patient with malignant systemic mastocytosis using a total intravenous anesthetic technique. Anesth Analg 1998 86 : 442 444.
20. Escribano C, Akin M. Castells et al. Mastocytosis: current concepts in diagnosis and treatment. Ann Hematol 2002 81 : 677 690.
21. Marone G, Spadaro G, Granata F et al. Treatment of mastocytosis: pharmacologic basis and current concepts. Leuk Res 2001 25 : 583 594.
22. Carter MC, Robyn JA, Bressler PB et al. Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis. J Allergy Clin Immunol 2007 119 : 1550 1551.
23. Heide R, Middelkamp Hup MA, Mulder PG et al. Mastocytosis Study Group Rotterdam. Clinical scoring of cutaneous mastocytosis. Acta Derm Venereol 2001 81 : 273 276.
24. Heide R, van Doorn K, Mulder PG et al. Serum tryptase and SCORMA (SCORing Mastocytosis)-index as disease severity parameters in childhood and adult cutaneous mastocytosis. Clin Exp Dermatol. 2008 In press).
25. Kiszewski AE, Alvarez-Mendoza A, Rios-Barrera VA et al. Mastocytosis in children: clinicopathological study based on 35 cases. Histopathology 2007 22 : 535 539.